Clinical Trial Update: Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on using a conditioning regimen of fludarabine and melphalan for patients with chronic lymphocytic leukemia, lymphoma, and multipl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Lymphoma
• Multiple Myeloma

Drugs mentioned

• Fludarabine (Fludarabine)
• Melphalan (Melphalan)

Snippet

Sponsor: Cooperative Study Group A for Hematology | Conditions: Chronic Lymphocytic Leukemia, Lymphoma | Phase 2 | Status: COMPLETED